Abstract
The yeast-inflamed rat paw model (1) has been used extensively to evaluate analgesic agents and a role for prostaglandins as mediators of hyperalgesia in this model is well accepted. In 1965 Winter and Flataker (2) showed that non-steroidal anti-inflammatory drugs inhibited the yeast-induced hyperalgesia without affecting oedema and later, Tyers and Haywood (3) proposed that prostaglandins, in particular PGE2, acted by sensitising primary afferent neurones to stimulation by other nociceptive agents. More recently, attention has focused on the possible role of lipoxygenase metabolites as mediators of hyperalgesia and oedema in this model. Rackham and Ford-Hutchinson (4) showed that LTB4 reversed the initial hypoalgesia and shortened the onset of hyperalgesia when injected concomitantly with yeast, in a similar manner to PGE1. However, rather than having a pro-inflammatory effect, LTB4 reduced the yeast-induced oedema. In similar experiments, line peptidyl leukotriene, LTD4, had no effect on yeast-induced hyperalgesia or oedema.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Randall, L.O. and Selitto, J.J. (1957). A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. 111, 409–419.
Winter, C.A. and Flataker, L. (1965). Nociceptive thresholds as affected by parenteral administration of irritants and of various anti-nociceptive drugs. J. Pharmacol. Exp. Ther., 148, 373–379.
Tyers, M.B. and Haywood, H. (1979). Effects of prostaglandins on peripheral nociceptors in acute inflammation. In Prostaglandins and Inflammation (eds. K.D. Rainsford and A.W. Ford-Hutchinson) Birkhauser, Basel, pp. 65–78.
Rackham, A. and Ford-Hutchinson, A.W. (1983). Inflammation and pain sensitivity: effects of leukotrienes D4, B4. and prostaglandin E1 in the rat paw. Prostaglandins, 25, 193–203.
Forder, R.A. and Carey, F. Paper in preparation.
Masters, D.J. and McMillan, R.M. (1983). Improved reversed phase HPLC assay for LTB4. In Leukotrienes and other Lipoxygenase Products (ed. P.J. Piper) Wiley, Chichester, pp. 275–276.
Dahlen, S-E., Bjork, J., Hedqvist, P., Arfors, K-E., Hammarstrom, S., Lindgren, J-A. and Samuelsson, B. (1981). Leukotrienes promote plasma leakage and leukocyte adhesion in posteapillary venules: In vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA, 78, 3887–3891.
Peck, M.J., Piper, P.J. and Williams, T.J. (1981). The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. Prostaglandins, 21, 315–321.
Ford-Hutchinson, A.W., Bray, M.A., Doig, M.V., Shipley, M.E. and Smith, M.J.H. (1980). Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature, 286, 264–265.
Goetzl, E.J. and Pickett, W.C. (1980). The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J. Immunol., 125, 1789–1791.
Wedmore, C.V. and Williams, T.J. (1981). Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature, 289, 646–650.
Simmons, P.M., Salmon, J.A. and Moncada, S. (1983). The release of leukotriene B4 during experimental inflammation. Biochem. Pharmac, 32, 1353–1359.
Levine, J.D., Lau, W., Kwiat, G. and Goetzl, E.J. (1984). Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science, 225, 743–745.
Palmer, R.M.J. and Yeats, D.A. (1981). Leukotriene B: A potent chemotactic agent and stimulus for lysosomal enzyme secretion for human neutrophils (PMN). Brit. J. Pharmacol., 73, 260–261P.
Editor information
Editors and Affiliations
Copyright information
© 1985 The Contributors
About this chapter
Cite this chapter
Haworth, D., Carey, F. (1985). Identification of Immunoreactive LTB4 in the Yeast-inflamed Rat Paw. In: Higgs, G.A., Williams, T.J. (eds) Inflammatory Mediators. Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07834-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-349-07834-9_4
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-07836-3
Online ISBN: 978-1-349-07834-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)